產(chǎn)品中心Cell Resources
聯(lián)系我們CONTACT US
400-999-210024小時服務熱線
產(chǎn)品概述
名稱 | C918 (人眼脈絡黑色素瘤細胞) (STR鑒定正確) |
種屬 | 人 |
生長特性 | 貼壁細胞 |
細胞形態(tài) | 多角形 |
凍存條件 | 凍存液:55% 基礎培養(yǎng)基+40%FBS+5%DMSO 溫度:液氮 |
培養(yǎng)方案A(默認) |
培養(yǎng)條件:
氣相:空氣,95%;CO2,5%, 溫度:37℃
|
推薦傳代比例 | 1:2-1:4 |
推薦換液頻率 | 2-3次/周 |
背景描述 | STR檢測發(fā)現(xiàn),三株人侵襲性脈絡膜黑色素瘤細胞C918、M619和Mum-2B為同一遺傳背景。 |
細胞類型 | 腫瘤細胞 |
腫瘤類型 | 黑色素瘤細胞 |
STR鑒定
-
STR位點信息
Amelogenin X CSF1PO 10,11 D2S1338 24,25 D3S1358 16 D5S818 11,12 D7S820 12 D8S1179 13 D13S317 11 D16S539 8,12 D18S51 15 D19S433 13,14 D21S11 30 FGA 21 PentaD 9,13 PentaE 7,13 TH01 8,9.3 TPOX 11 vWA 16,17 D6S1043 11,12 D12S391 17,22 D2S441 11,14 -
STR鑒定圖
-
參考文獻
-
Local anesthetic tetracaine hydrochloride induces pyroptosis via caspase-3/gasdermin E in uveal melanoma (2024-09-24)
期刊:BIOMEDICINE & PHARMACOTHERAPY
DOI:10.1016/j.biopha.2024.117471
影響因子 :6.9
引用產(chǎn)品: A-375 細胞 , HMY-1 細胞 , C918 細胞 , 293T [HEK-293T] 細胞 , A2058 細胞
-
TREM2, a critical activator of pyroptosis, mediates the anti?tumor effects of piceatannol in uveal melanoma cells via caspase 3/GSDME pathwayTREM2, a critical activator of pyroptosis, mediates the anti?tumor effects of piceatannol in uveal melanoma cells via caspase 3/GSDME pathway (2024-08-30)
期刊:INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
影響因子 :5.7
引用產(chǎn)品: C918 細胞
-
Integrating network pharmacology, molecular docking and experimental verification to reveal the mechanism of artesunate in inhibiting choroidal melanoma (2024-08-09)
期刊:Frontiers in Pharmacology
DOI:10.3389/fphar.2024.1448381
影響因子 :4.4
引用產(chǎn)品: C918 細胞
-
Ang-1 promotes tumorigenesis and mediates the anti-cancer effects of Artesunate on Choroidal melanoma via the regulation of Akt/mTOR signaling pathway (2024-09-27)
期刊:CYTOKINE
DOI:10.1016/j.cyto.2024.156771
影響因子 :3.7
引用產(chǎn)品: C918 細胞
-
Artesunate attenuates the tumorigenesis of choroidal melanoma via inhibiting EFNA3 through Stat3/Akt signaling pathway (2024-04-17)
期刊:JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
DOI:10.1007/s00432-024-05711-8
影響因子 :3.6
引用產(chǎn)品: C918 細胞
-
PLEK2: a potential biomarker for metastasis and prognostic evaluation in uveal melanoma (2024-12-02)
期刊:Frontiers in Medicine
影響因子 :3.1
引用產(chǎn)品: C918 細胞
-
Cooperative phototherapy based on bimodal imaging guidance for the treatment of uveal melanoma (2023-05-04)
期刊:JOURNAL OF NANOBIOTECHNOLOGY
DOI:10.1186/s12951-023-01891-6
影響因子 :10.2
引用產(chǎn)品: C918 細胞 , ARPE-19 細胞
-
Development of Uveal Melanoma-Specific Aptamer for Potential Biomarker Discovery and Targeted Drug Delivery (2023-02-22)
期刊:ANALYTICAL CHEMISTRY
DOI:10.1021/acs.analchem.3c00005
影響因子 :7.4
引用產(chǎn)品: C918 細胞 , ARPE-19 細胞
-
Identification of a novel immune-related gene signature for prognosis and the tumor microenvironment in patients with uveal melanoma combining single-cell and bulk sequencing data (2023-01-30)
期刊:Frontiers in Immunology
DOI:10.3389/fimmu.2023.1099071
影響因子 :7.3
引用產(chǎn)品: ARPE-19 細胞 , C918 細胞
-
Hypomethylation of CD3D promoter induces immune cell infiltration and supports malignant phenotypes in uveal melanoma (2023-08-31)
期刊:FASEB JOURNAL
影響因子 :4.8
引用產(chǎn)品: C918 細胞
-
miRNA-145/miRNA-205 inhibits proliferation and invasion of uveal melanoma cells by targeting NPR1/CDC42 (2020-05-18)
期刊:International Journal of Ophthalmology
影響因子 :1.4
引用產(chǎn)品: C918 細胞
FAQs
Q:{{item.question}}
A:
產(chǎn)品資料


識別碼示意圖